Week of December 6, 2022 | Vol. 11, Issue 47


In This Issue

Upcoming Events

Industry M&A Activity

Recent Transactions

Trading Comps

Market Reports

M&A Pipeline

Featured Headlines

Tanner Updates

Quick Links

Who We Are

M&A Discussion Group

Daybreak Consumer Care

Carlin Consumer Health

Contact Information

Xan Smith

Managing Director

Business Development


Jeremy C. Johnson

Managing Director

Head of M&A and Capital Advisory


Industry Snapshot
Above is an overview of recent industry M&A activity. Click on the chart to view complete transaction tables broken out by industry sub sectors. For additional information, see the Industry M&A Activity section below.
Events Hosted or Attended by Bourne Partners

JP Morgan Healthcare Conference

January 9-12, 2023 - San Francisco, CA

SCOPE Summit for Clinical Ops Executives

February 6-9, 2023 - Orlando, FL

DCAT Week 2023

March 20-23, 2023 - New York City, NY

Recent Transactions, Trading Comps, Market Reports, M&A Pipeline
An Overview of Transactions Within Market Sub-segments
Below are summaries and charts with the past week's transactions from the different healthcare sectors. For a detailed table showing data for each industry transaction click on any of the charts. Total transaction values are provided in USD millions.

Pharma & Biotech

7 transactions totaling $400 million

Supplies, Equipment & Services

28 transactions totaling $1,501 million

Healthcare Facilities & Distributors

15 transactions totaling $805 million

Healthcare IT & Managed Care

5 transactions totaling $52 million


Pharma & Biotech

37 transactions totaling $479 million

Supplies, Equipment & Services

25 transactions totaling $157 million

Healthcare Facilities & Distributors

1 transaction

Healthcare IT & Managed Care

13 transactions totaling $201 million


Pharma & Biotech

17 transactions totaling $777 million

Supplies, Equipment & Services

11 transactions totaling $1,577 million

Healthcare Facilities & Distributors

1 transaction

Healthcare IT & Managed Care

0 transactions

A Breakdown of Relevant Trading Multiples
This is a high-level breakdown of median revenue and EBITDA multiples for each of the specific sub sectors.

Insight Into Healthcare Related Industries

Pharma Services Sector Snapshot 1H 2022

August 2022

Market Insight Capital Markets Update

October 2022


Representative Current Retained Sell-Side And Partnering Opportunities

Project Beach

Pharma Services | Sell-Side

Acquisition opportunity of Clinical Trial Services Provider

Project Panther

Pharma Services | Sell-Side

Acquisition opportunity of US OTC CDMO

Project Ester

Consumer Health | Strategic Partnering 

Partnering opportunity for launch and commercialization of novel OTC dry eye product

Project Jazz

Pharma Services | Sell-Side

Acquisition opportunity of US compounding pharmacy and pharmacy services provider

Project Gateway

Pharma | Sell-Side

Acquisition opportunity of US specialty generics platform and small portfolio

Project Power Play

Pharma | Buy-Side

Seeking established brands across all therapeutic categories or growth assets in Neurology / CNS

Project Trident

Pharma | Buy-Side

Seeking generic liquids or established brands across all formats sold through the hospital / institutional channel


A Sampling of Industry Headlines

LTS and Micron announce collaboration for commercial manufacturing of Micro Array Patch (MAP) technology

LTS Lohmann - November 28, 2022

AstraZeneca sells US plant to Resilience, forging manufacturing pact in the process

Fierce Pharma- November 29, 2022

Emplicure AB and Quotient Sciences Announce an Integrated Manufacturing and Clinical Testing Partnership for Emplicure’s First Clinical Pharmacokinetic Study for EMPLI03

Quotient Sciences - November 29, 2022

Almirall signs on for European clinical trial project to collect data for patients

Fierce Biotech - November 29, 2022

Alcami Builds CGMP Biostorage Facility in NC

Alcami - December 1, 2022

Catalent Completes Expansion of Clinical Supply Facility in Shanghai, China

Catalent - December 1, 2022

WuXi STA and Multiply Labs Announce Partnership and Successfully Deploy Robotic Manufacturing System for Personalized Drugs

Business Wire - December 1, 2022

Reaction Biology Acquires Bioassay GmbH Increasing Large Molecule Capabilities Within Its Robust Portfolio of Drug Discovery and Development Services

PR Newswire - December 2, 2022



Enabling Access to Medicine

There are different instances where patients may experience interruptions in treatment access, entirely lose access they once had, or completely lack access to a commercialized medicine that just isn’t available where they live. Tanner EVPs Maryori Alvarenga and John Lagus share more about these access issues and the opportunities to overcome them. Access the full article here.

Early Access Pathways to Medicines

Early Access Pathways to MedicinesIn this collaborative article we take a look at early access pathways from the viewpoint of different stakeholders involved in the process of making a medicine available for a patient with an unmet medical need. Read the complete write-up here.